vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and DiamondRock Hospitality Co (DRH). Click either name above to swap in a different company.
DiamondRock Hospitality Co is the larger business by last-quarter revenue ($258.2M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 5.6%, a 2.6% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 1.3%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -8.6%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
DiamondRock Hospitality Co is a US-based real estate investment trust owning and operating a portfolio of premium upscale hotels and resorts. Its properties are mainly located in major urban tourist and business hubs nationwide, catering to both leisure and corporate clientele seeking high-quality accommodation services.
COLL vs DRH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $258.2M |
| Net Profit | $17.0M | $14.5M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 11.1% |
| Net Margin | 8.3% | 5.6% |
| Revenue YoY | 12.9% | 1.3% |
| Net Profit YoY | 35.3% | 22.0% |
| EPS (diluted) | $0.48 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $258.2M | ||
| Q4 25 | $205.4M | $274.5M | ||
| Q3 25 | $209.4M | $285.4M | ||
| Q2 25 | $188.0M | $305.7M | ||
| Q1 25 | $177.8M | $254.9M | ||
| Q4 24 | $181.9M | $279.1M | ||
| Q3 24 | $159.3M | $285.1M | ||
| Q2 24 | $145.3M | $309.3M |
| Q1 26 | — | $14.5M | ||
| Q4 25 | $17.0M | $26.2M | ||
| Q3 25 | $31.5M | $22.5M | ||
| Q2 25 | $12.0M | $40.8M | ||
| Q1 25 | $2.4M | $11.9M | ||
| Q4 24 | $12.5M | $-11.2M | ||
| Q3 24 | $9.3M | $26.4M | ||
| Q2 24 | $19.6M | $24.5M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | 11.1% | ||
| Q4 25 | 29.6% | 8.9% | ||
| Q3 25 | 29.7% | 8.1% | ||
| Q2 25 | 18.7% | 13.7% | ||
| Q1 25 | 12.2% | 4.3% | ||
| Q4 24 | 20.9% | -3.7% | ||
| Q3 24 | 21.9% | 9.5% | ||
| Q2 24 | 32.7% | 8.4% |
| Q1 26 | — | 5.6% | ||
| Q4 25 | 8.3% | 9.5% | ||
| Q3 25 | 15.0% | 7.9% | ||
| Q2 25 | 6.4% | 13.4% | ||
| Q1 25 | 1.4% | 4.7% | ||
| Q4 24 | 6.9% | -4.0% | ||
| Q3 24 | 5.9% | 9.3% | ||
| Q2 24 | 13.5% | 7.9% |
| Q1 26 | — | $0.07 | ||
| Q4 25 | $0.48 | $0.12 | ||
| Q3 25 | $0.84 | $0.10 | ||
| Q2 25 | $0.34 | $0.18 | ||
| Q1 25 | $0.07 | $0.04 | ||
| Q4 24 | $0.36 | $-0.06 | ||
| Q3 24 | $0.27 | $0.11 | ||
| Q2 24 | $0.52 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $39.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.4B |
| Total Assets | $1.7B | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $39.3M | ||
| Q4 25 | $386.7M | $68.1M | ||
| Q3 25 | $285.9M | $145.3M | ||
| Q2 25 | $222.2M | $52.4M | ||
| Q1 25 | $197.8M | $100.6M | ||
| Q4 24 | $162.8M | $81.4M | ||
| Q3 24 | $120.0M | $75.3M | ||
| Q2 24 | $271.6M | $125.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.2B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $301.7M | $1.4B | ||
| Q3 25 | $274.8M | $1.6B | ||
| Q2 25 | $232.2M | $1.6B | ||
| Q1 25 | $234.4M | $1.6B | ||
| Q4 24 | $228.8M | $1.6B | ||
| Q3 24 | $234.3M | $1.6B | ||
| Q2 24 | $216.6M | $1.6B |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $1.7B | $3.0B | ||
| Q3 25 | $1.6B | $3.1B | ||
| Q2 25 | $1.6B | $3.1B | ||
| Q1 25 | $1.6B | $3.1B | ||
| Q4 24 | $1.7B | $3.2B | ||
| Q3 24 | $1.6B | $3.2B | ||
| Q2 24 | $1.1B | $3.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.65× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.69× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $67.9M | ||
| Q3 25 | $78.4M | $74.6M | ||
| Q2 25 | $72.4M | $73.6M | ||
| Q1 25 | $55.4M | $27.6M | ||
| Q4 24 | $84.6M | $75.8M | ||
| Q3 24 | $-9.0M | $61.7M | ||
| Q2 24 | $67.4M | $55.7M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $47.3M | ||
| Q3 25 | $78.3M | $54.9M | ||
| Q2 25 | $72.4M | $57.9M | ||
| Q1 25 | $54.6M | $2.0M | ||
| Q4 24 | $84.1M | $52.6M | ||
| Q3 24 | $-9.2M | $39.0M | ||
| Q2 24 | $67.1M | $38.8M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 17.2% | ||
| Q3 25 | 37.4% | 19.2% | ||
| Q2 25 | 38.5% | 18.9% | ||
| Q1 25 | 30.7% | 0.8% | ||
| Q4 24 | 46.2% | 18.9% | ||
| Q3 24 | -5.8% | 13.7% | ||
| Q2 24 | 46.2% | 12.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 7.5% | ||
| Q3 25 | 0.1% | 6.9% | ||
| Q2 25 | 0.0% | 5.1% | ||
| Q1 25 | 0.4% | 10.0% | ||
| Q4 24 | 0.3% | 8.3% | ||
| Q3 24 | 0.2% | 7.9% | ||
| Q2 24 | 0.2% | 5.5% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 2.59× | ||
| Q3 25 | 2.49× | 3.31× | ||
| Q2 25 | 6.05× | 1.80× | ||
| Q1 25 | 22.92× | 2.33× | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 2.33× | ||
| Q2 24 | 3.44× | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
DRH
| Rooms | $164.1M | 64% |
| Food and beverage | $67.2M | 26% |
| Other | $26.9M | 10% |
